§ BIOTECHNOLOGY
USD · BiotechnologyKRRO
KORRO BIO INC
USDSector · Biotechnology
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
69 increased/new, 25 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| Lynx1 Capital Management LP | 1.5M | 2.8% | +127% |
| NEA Management Company, LLC | 1.3M | 0.8% | +19% |
| Atlas Venture Life Science Advisors, LLC | 1.1M | 1.6% | ±0% |
| Balyasny Asset Management | 1.0M | 0.0% | n/a |
| Venrock Adviser, LLC | 1.0M | 0.4% | n/a |
| Affinity Asset Advisors, LLC | 707K | 0.4% | n/a |
◇ AC INTELLIGENCE
Top institutional owners for KRRO as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER5.7% · 0 holders
OTHER75.6% · 69 holders
TACTICAL / MACRO9.5% · 3 holders
PASSIVE / INDEX4.6% · 6 holders
DEALER / BANK2.9% · 14 holders
SYSTEMATIC / QUANT1.4% · 5 holders
QUALITY / COMPOUNDER0.3% · 2 holders
INCOME / DEFENSIVE0.0% · 2 holders
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for KRRO in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention KRRO yet.